Divestiture

6 Months Ended

Mar. 31, 2013

Discontinued Operations And Disposal Groups [Abstract]

Divestiture

Note 10 – Divestiture

On October 31, 2012, the Company completed the sale of its BD Biosciences—Discovery Labware unit, excluding its Advanced Bioprocessing platform, to Corning Incorporated. Gross cash proceeds from the sale were approximately $724,071, and the Company recognized a pre-tax gain on sale from this divestiture of $561,749. The after-tax gain recognized from this divestiture was $346,555. As a result of this divestiture, the Company derecognized $16,601 of goodwill, allocated based upon the relative fair values of the disposed assets.

The Company agreed to perform some contract manufacturing and other transition services for a defined period after the sale; however, the Company will not have the ability to exert significant influence over the Discovery Labware disposal group after the sale, and cash flows associated with these activities are not expected to be material. The net cash flows from these activities are reported in the Condensed Consolidated Statements of Income as Other income (expense).

The results of operations associated with the Discovery Labware disposal group are reported as discontinued operations for all periods presented in the accompanying Condensed Consolidated Statements of Income and Cash Flows and related disclosures.

Results of discontinued operations were as follows:

	Three Months Ended March 31,					Six Months Ended March 31,
	2013			2012		2013		2012
Revenues	$	—		$	61,879	$	20,196	$	117,853
(Loss) income from discontinued operations before income taxes		(1,660	)		23,453		569,863		45,221
Less income tax (benefit) provision		(1,177	)		7,544		215,160		14,871
(Loss) income from discontinued operations, net	$	(483	)	$	15,909	$	354,703	$	30,350